Mrakic-Sposta, S.; Gussoni, M.; Montorsi, M.; Vezzoli, A.
Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414. Antioxidants 2021, 10, 836.
https://doi.org/10.3390/antiox10060836
AMA Style
Mrakic-Sposta S, Gussoni M, Montorsi M, Vezzoli A.
Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414. Antioxidants. 2021; 10(6):836.
https://doi.org/10.3390/antiox10060836
Chicago/Turabian Style
Mrakic-Sposta, Simona, Maristella Gussoni, Michela Montorsi, and Alessandra Vezzoli.
2021. "Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414" Antioxidants 10, no. 6: 836.
https://doi.org/10.3390/antiox10060836
APA Style
Mrakic-Sposta, S., Gussoni, M., Montorsi, M., & Vezzoli, A.
(2021). Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414. Antioxidants, 10(6), 836.
https://doi.org/10.3390/antiox10060836
